Mylotarg® Sensitivity (CD33)

The Mylotarg® Sensitivity (CD33) test contains 1 test with 3 biomarkers.

Campath®-1H (Alemtuzumab) is an antibody targeted to CD52, an antigen expressed on the surface of chronic lymphocytic cells. Drug sensitivity can be performed prior to the initiation of therapy to potentially avoid toxicity.

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Also known as: Mylotarg Sensitivity CD33

Result:

Sample Description:

Viability:

*Process times are an estimate and are not guaranteed. The lab may need additional time due to weather, holidays, confirmation/repeat testing, or equipment maintenance.